In the past years, members of the IBC2 have been very successful in securing external funding either through initiation of large-scale collaborative projects, through participation in other collaborative program grants, or by applying for individual grants.
IBC2 director Ivan Dikic is the speaker of a Collaborative Research Centre (CRC/SFB) on selective autophagy (SFB 1177) and holds an ERC Advanced Grant. He has also been part of the managing board for the Cluster of Excellence Macromolecular Complexes since 2009, is part of the board of the LOEWE Center Frankfurt Cancer Institute (FCI) and the local DKTK and Sructural genomics Consortium (SGC) steering committees. IBC2 scientists lead projects in several other research networks funded through schemes by the German Research Foundation (DFG), the European Commission, and the Hessian Ministry of Higher Education, Research, and the Arts (HMWK).
The list of current grant providers for ongoing individual projects and fellowships includes the DFG, the European Research Council, the Alexander von Humboldt Foundation, the Boerhinger Ingelheim Foundation, the Axa Foundation and the Human Frontier Science Program (HFSP). Early career scientists at the IBC2 are encouraged and mentored to apply for independent funding and have obtained numerous competitive grants, some of which are still running, e.g. Emmy Noether Fellowships (Christian Münch, Anja Bremm as well as alumni Christian Behrends and Krishna Rajalingam), PLUS 3 Fellowships (alumni Christian Behrends and Krishna Rajalingam), and ERC Starting Grants (Christian Münch as well as alumni Christian Behrends).